Neoleukin Therapeutics Inc
NLTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.2M
Close$
$6.08
74.2% upside
Current Fair Value
74.2% upsideUndervalued by 74.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.20 Million |
|---|---|
| Enterprise Value | $-106,831,315.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 1.1 |
| Outstanding Shares | 22,305,734 |
Return
| Return on Equity | -41.48% |
|---|---|
| Return on Assets | -37.48% |
| Return on Invested Capital | -45.34% |
Valuation & Multiples
| P/E Ratio | -0.79 |
|---|---|
| PEG | -2.16 |
| Price to Sales | - |
| Price to Book Ratio | 0.35 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.96 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data